Roche and Dexcom today announced the signing of a definitive distribution agreement for the Dexcom One CGM blood glucose monitoring system. Under the terms of the agreement, Roche will distribute the product in Italy. CGM Dexcom One is a simplified and cost effective continuous blood glucose monitoring system that shares the same innovative tracking hardware as the Dexcom G6. Dexcom One is suitable for people with type 1 or type 2 diabetes who use insulin. This meter uses a small wearable sensor and transmitter to wirelessly measure and send real-time blood glucose readings to a compatible smart device via the Dexcom One App. This eliminates the need for painful fingertip punctures. The App also displays trend arrows that display the speed and direction of glucose levels, facilitating real-time treatment decisions and helping people with diabetes avoid potentially dangerous hyperglycemic or hypoglycemic events. With this partnership – the note continues – Roche continues to implement its vision aimed at promoting the transformation of healthcare facilities and access to innovation in the market, allowing people with diabetes to manage their therapy with confidence. The agreement allows both partners to better respond to the unmet needs of people with diabetes, caregivers and healthcare professionals in Italy, while underlining their commitment to offering people with diabetes solutions that integrate seamlessly into their routine. daily and improve the quality of life. “In our effort to bring true relief to people with diabetes and their carers, we are thrilled to partner with Dexcom to expand our open ecosystem,” said Pedro Goncalves, Head of Global Commercial, Roche Diabetes Care. potential in this collaboration, to promote the choice and further simplification of daily therapy management for people with diabetes and healthcare professionals. It will allow us to accelerate access to a leading and cost effective CGM system, thereby reducing immense the daily burden of this chronic disease on people, on society and on the Italian health system “. “Dexcom is committed to providing greater access to continuous glucose monitoring for people with diabetes around the world,” said Erik Bjorkman, Dexcom Senior Vice President, General Manager EMEA. This distribution agreement signed with Roche will accelerate our ability to make the life-changing Dexcom One CGM system, widely available to people with diabetes in Italy. By leveraging the solid team and resources that Roche already has in Italy, we will be able to bring Dexcom One to market quickly, efficiently and at a more people, offering Italian patients an easier and more accessible way to manage diabetes with Dexcom CGM. ” Roche Diabetes Care, the world leader in integrated and personalized diabetes management, promotes sustainable care to improve the lives of people with diabetes. The company connects its devices and digital solutions, such as mySugr, one of the most popular diabetes management apps in the world, as well as third-party devices and services in an open ecosystem. Localization and registration activities at the Italian Ministry of Health are already underway for Dexcom One. Both partners are now working jointly with the aim of making the system available to Italian patients as early as the next few months.
Welcome! Log into your account
Recover your password
A password will be e-mailed to you.